Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 16 ... Failure, Takeda Pharmaceutical Company Ltd., Therapy, Transfusion Medicine, Treatment, Affymax Inc. This article was prepared by Biotech Business Week editors from staff and ...
2009 JUN 29 ... Pharmaceuticals Inc., Pharmaceutical Business, Pharmaceutical Company, Renal Failure, Affymax Inc.
This article was prepared by Biotech Business Week editors from staff ...
2009 JUL 27 ... autoimmune and inflammatory diseases, announced that Arlene Morris, president and CEO of Affymax, Inc. (Nasdaq:AFFY), has been elected chairperson of the company's Board of Directors. ...
2009 SEP 21 ... Drugs, Kidney, Nephrology, Pharmaceuticals, Renal Failure, Therapy, Treatment, Affymax Inc. This article was prepared by Biotech Business Week editors from staff and ...
2009 APR 13 ... Disease, Nephrology, Proteomics, Renal Dialysis, Renal Failure, Therapy, Treatment, Affymax Inc.
This article was prepared by Biotech Business Week editors from staff ...
2009 NOV 2 ... Business, Pharmaceuticals, Renal Failure, Takeda Pharmaceutical Company Ltd., Affymax Inc. This article was prepared by Biotech Business Week editors from staff and ...
2009 JUN 8 ... Trial Research, Dialysis, Kidney Disease, Nephrology, Renal Disease, Renal Function, Affymax Inc.
This article was prepared by Biotech Business Week editors from staff ...
2009 NOV 1 ... panel featuring Hakan Bjorklund, PhD - CEO, Nycomed; Arlene Morris - President and CEO, Affymax; Ian Nicholson, MBA - CEO, Chroma Therapeutics; and Dan Zabrowski - PhD, Global Head of ...
2009 NOV 1 ... Dr. Levitt was also Chief Operating Officer and Head of Research and Development at Affymax, Inc., where he spearheaded all aspects of that company's research, development, and ...
2009 FEB 23 ... Management at Northwestern University. He currently serves on the Board of Directors of Affymax, Inc., Transcept Pharmaceuticals, Inc., and Evotec AG.
Keywords: ...
2009 OCT 19 ... and, in addition to the SEC, will include presentations from firms such as Cell Genesys, Affymax, BioMarin Pharmaceuticals, Monogram Biosciences, Inc., Oncomed and Poniard ...
2009 AUG 17 ... officer of biotechnology company Camitro Corporation. From 1992 to 1999, he worked at Affymax Research Institute, the drug discovery technology development center for Glaxo Wellcome ... PDL BioPharma, Inc. (PDL) (NASDAQ:PDLI) announced the appointment of Harold E. ("Barry") Selick, Ph.D., ...
2009 MAR 16 ... 2009;104(2):155-163).
For more information, contact K.W. Woodburn, Affymax Inc., 4001 Miranda Avenue, Palo Alto, CA 94304, USA.
Publisher contact ...
2009 AUG 10 ... Squibb in 2008. Ms. Kim's additional industry experience includes senior positions at Affymax, Onyx Pharmaceuticals, Protein Design Labs and Chiron Corporation. In addition to her ... Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) announced that Helen S. Kim has been appointed to the company's Board of ...
